# zilganersen

NDC: 68225-282
Generic name: zilganersen
Labeler / Manufacturer: Patheon Italia S.p.A.
Product type: DRUG FOR FURTHER PROCESSING
Marketing category: DRUG FOR FURTHER PROCESSING
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: —
Marketing started: 20260904



## Active ingredients

- ZILGANERSEN SODIUM: 56 mg/2.8mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68225-282"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68225-282